Our Values: Built on Trust. Driven by Science.

---

Why Values Matter in the Age of AI

We stand at the intersection of two powerful forces: Artificial Intelligence and the fight against rare, complex, and high-velocity diseases. While AI offers unprecedented speed, it also brings risks regarding privacy and ethics.

At Regal Intel, we believe that technology is only as good as the values that govern it. As a 501(c)(3) non-profit, we are not beholden to shareholders or quarterly profits. We are beholden to the patients who are waiting for answers. These are the core values that guide every line of code we write and every partnership we build.

Data Sovereignty

Your Data, Your Rules. We believe that patient data should never be treated as a commodity to be bought and sold. It is a sovereign asset of the patient and the hospital that cares for them.

• Our Commitment: We operate on a strict no exfiltration model. We bring our algorithms to the data via our "Code-to-Data" diagnostics framework, ensuring that sensitive patient records never leave the hospital’s secure firewall. We prove that you don't have to sacrifice privacy to achieve population-scale progress.

Patient Primacy

The Patient is the North Star. In the complex world of biotech—full of investors, regulators, and endpoints—it is easy to lose sight of the human being at the center. We exist to make the "invisible" patient visible, using diagnosis intelligence to intercept the "Metabolic Masqueraders" hiding in plain sight.

• Our Commitment: We measure success by one metric: Impact on the Patient Journey. If a project generates revenue but doesn't accelerate a diagnosis or rescue a stranded therapy, we don't do it. Ending the 7-year Diagnostic Odyssey is our ultimate mandate.

Scientific Rigor

Evidence Over Hype. Rare disease research suffers from data scarcity, but that is no excuse for low standards. We believe that "Real-World Evidence" must be synonymous with "Regulatory-Grade Evidence."

• Our Commitment: We hold our diagnosis intelligence and our researchers to the highest scientific standards. We do not cut corners on validation, because we know that bad data doesn't just fail a trial—it fails a family waiting for hope.

Radical Collaboration

Silos are the Enemy. No single hospital, biotech company, or research institute can solve a rare disease alone. The numbers are too small. Success requires a consortium.

• Our Commitment: We build bridges, not walls. As a non-profit, we facilitate collaboration across the entire ecosystem—connecting academic research hubs with rural community hospitals, and empowering patient foundations to speak directly to pharma sponsors. We create a shared ecosystem where diagnosis intelligence is abundant and accessible.

Urgency

Time is not on our side. For many rare and high-velocity diseases, "standard of care" is a ticking clock. We operate with the understanding that every day a diagnosis is delayed is a day of irreversible physiological progression.

• Our Commitment: We build for speed. We automate what can be automated and deploy our diagnostics framework to calculate the biological velocity of a patient's symptoms so we can trigger early interventions. We equip human doctors with actionable diagnosis intelligence to focus on what they do best: intercepting a crisis before the damage becomes permanent.

A Promise to Our Community

We invite our partners—hospitals, donors, patient advocacy groups, and developers—to hold us accountable to these values. We are building the future of rare, complex, and high-velocity disease research, and we are building it on a foundation of absolute integrity.